(Q41338314)

29 September 2017

1 reference

title

The positive influence of Nef on viral infectivity (English)

1 reference

29 September 2017

1 reference

Guatelli JC

1

1 reference

29 September 2017

publication date

1 January 1997

1 reference

29 September 2017

1 reference

29 September 2017

volume

148

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

34-37

1 reference

Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Serine phosphorylation-independent downregulation of cell-surface CD4 by nef

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

Phosphorylation of Vif and its role in HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2897%2981910-3

7 January 2021

10.1016/S0923-2516(97)81910-3

Identifiers

DOI

1 reference

29 September 2017

1 reference